Altered PDE10A expression detectable early before symptomatic onset in Huntington’s disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Altered PDE10A expression detectable early before symptomatic onset in Huntington’s disease
Authors
Keywords
-
Journal
BRAIN
Volume 138, Issue 10, Pages 3016-3029
Publisher
Oxford University Press (OUP)
Online
2015-09-26
DOI
10.1093/brain/awv214
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vivo Assessment and Dosimetry of 2 Novel PDE10A PET Radiotracers in Humans: 18F-MNI-659 and 18F-MNI-654
- (2014) O. Barret et al. JOURNAL OF NUCLEAR MEDICINE
- Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human
- (2014) C. Plisson et al. JOURNAL OF NUCLEAR MEDICINE
- The Phosphodiesterase 10 Positron Emission Tomography Tracer, [18F]MNI-659, as a Novel Biomarker for Early Huntington Disease
- (2014) David S. Russell et al. JAMA Neurology
- Connectivity-Based Functional Analysis of Dopamine Release in the Striatum Using Diffusion-Weighted MRI and Positron Emission Tomography
- (2013) Andri C. Tziortzi et al. CEREBRAL CORTEX
- Metabolic network as a progression biomarker of premanifest Huntington’s disease
- (2013) Chris C. Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- Elevated arteriolar cerebral blood volume in prodromal Huntington's disease
- (2013) Jun Hua et al. MOVEMENT DISORDERS
- Concurrent activation of striatal direct and indirect pathways during action initiation
- (2013) Guohong Cui et al. NATURE
- Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice
- (2013) Y.P. Deng et al. NEUROBIOLOGY OF DISEASE
- PET imaging shows loss of striatal PDE10A in patients with Huntington disease
- (2013) R. Ahmad et al. NEUROLOGY
- Selective inhibition of phosphodiesterase 10A impairs appetitive and aversive conditioning and incentive salience attribution
- (2013) Elisabeth Piccart et al. NEUROPHARMACOLOGY
- Differential striatal spine pathology in Parkinson’s disease and cocaine addiction: A key role of dopamine?
- (2013) R.M. Villalba et al. NEUROSCIENCE
- The organization of the human striatum estimated by intrinsic functional connectivity
- (2012) Eun Young Choi et al. JOURNAL OF NEUROPHYSIOLOGY
- Brain metabolite alterations and cognitive dysfunction in early Huntington's disease
- (2012) Paul G. Unschuld et al. MOVEMENT DISORDERS
- Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease
- (2012) Alessandro Leuti et al. NEUROBIOLOGY OF DISEASE
- Dopamine D1, D2, D3 Receptors, Vesicular Monoamine Transporter Type-2 (VMAT2) and Dopamine Transporter (DAT) Densities in Aged Human Brain
- (2012) Jianjun Sun et al. PLoS One
- Fluid and white matter suppression with the MP2RAGE sequence
- (2011) Mark Tanner et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Radiosynthesis and in vivo evaluation of [11C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A
- (2011) Christophe Plisson et al. NUCLEAR MEDICINE AND BIOLOGY
- Dopamine and Glutamate in Huntington's Disease: A Balancing Act
- (2010) Véronique M. André et al. CNS Neuroscience & Therapeutics
- Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: A multimodal imaging study
- (2010) Marios Politis et al. HUMAN BRAIN MAPPING
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
- Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy
- (2010) Andri C. Tziortzi et al. NEUROIMAGE
- Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease
- (2010) Carmela Giampà et al. PLoS One
- Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
- (2009) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease
- (2009) Carmela Giampà et al. NEUROBIOLOGY OF DISEASE
- A high resolution and high contrast MRI for differentiation of subcortical structures for DBS targeting: The Fast Gray Matter Acquisition T1 Inversion Recovery (FGATIR)
- (2009) Atchar Sudhyadhom et al. NEUROIMAGE
- Hypothalamic involvement in Huntington's disease: an in vivo PET study
- (2008) M. Politis et al. BRAIN
- Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington’s disease
- (2008) J.C.H. van Oostrom et al. EUROPEAN JOURNAL OF NEUROLOGY
- A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
- (2008) Maria Björkqvist et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Distinct Roles of PDE4 and PDE10A in the Regulation of cAMP/PKA Signaling in the Striatum
- (2008) A. Nishi et al. JOURNAL OF NEUROSCIENCE
- Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation
- (2008) S. Threlfell et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia
- (2008) C. J. Schmidt et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Detection of Huntington's disease decades before diagnosis: the Predict-HD study
- (2007) J S Paulsen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started